Earth Essences.Com

Relief for 1.7million Britons suffering urinary tract infections

Britons suffering agonising and recurring bladder infections could soon be treated with a new form of antibiotic that has never been used anywhere else in the world.

Experts have hailed gepotidacin as a huge step forward in the fight against antibiotic resistance, because the bugs have not had a chance to become resistant to its attacks. They believe this means it will be able to fight off aggressive urinary tract infections (UTIs) that don’t respond to current antibiotics.

Up to 1.7 million Britons – the majority of whom are women – suffer from chronic UTIs, classed as three or more infections a year.

Symptoms include a burning pain when going to the toilet, going more often than usual and feeling like you need to go when the bladder is empty. In older patients, the infection can cause a dementia-like condition called delirium. There is also a risk of sepsis, which accounts for about 50,000 deaths a year.

Symptoms include a burning pain when going to the toilet, going more often than usual and feeling like you need to go when the bladder is empty. In older patients, the infection can cause a dementia-like condition called delirium© Provided by Daily Mail

Gepotidacin is also expected to be used to treat a number of other diseases including the sexually transmitted infection gonorrhoea, which is one of the most drug-resistant bacterial diseases in the world. GSK, the pharmaceutical firm behind gepotidacin, plans to apply for US approval by spring, and experts say it will likely be given the NHS green light within the next two years.